Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016;4(4):29.
doi: 10.3390/proteomes4040029. Epub 2016 Oct 1.

Personalized Proteomics: The Future of Precision Medicine

Trevor T Duarte  1 , Charles T Spencer  1
Affiliations

Personalized Proteomics: The Future of Precision Medicine

Trevor T Duarte et al. Proteomes. 2016.

Abstract

Medical diagnostics and treatment has advanced from a one size fits all science to treatment of the patient as a unique individual. Currently, this is limited solely to genetic analysis. However, epigenetic, transcriptional, proteomic, posttranslational modifications, metabolic, and environmental factors influence a patient's response to disease and treatment. As more analytical and diagnostic techniques are incorporated into medical practice, the personalized medicine initiative transitions to precision medicine giving a holistic view of the patient's condition. The high accuracy and sensitivity of mass spectrometric analysis of proteomes is well suited for the incorporation of proteomics into precision medicine. This review begins with an overview of the advance to precision medicine and the current state of the art in technology and instrumentation for mass spectrometry analysis. Thereafter, it focuses on the benefits and potential uses for personalized proteomic analysis in the diagnostic and treatment of individual patients. In conclusion, it calls for a synthesis between basic science and clinical researchers with practicing clinicians to design proteomic studies to generate meaningful and applicable translational medicine. As clinical proteomics is just beginning to come out of its infancy, this overview is provided for the new initiate.

Keywords: biomarker; clinical proteomics; diagnostic; mass spectrometry; personalized medicine; pharmacokinetics; precision medicine; proteomics; therapeutic monitoring.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Scheme 1
Scheme 1
Workflow of clinical proteomic steps highlighting and placing in context examples from the text.
See this image and copyright information in PMC

References

    1. Specific Genetic Disorders. [(accessed on 16 June 2016)]; Available online: https://www.genome.gov/10001204/specific-genetic-disorders/
    1. Novelli G. Personalized genomic medicine. Intern. Emerg. Med. 2010;5(Suppl 1):S81–S90. doi: 10.1007/s11739-010-0455-9. - DOI - PubMed
    1. Jain K.K. Personalized medicine. Curr. Opin. Mol. Ther. 2002;4:548–558. - PubMed
    1. Altsuler D., Donnelly P., Gibbs R.A., Yang H., Zeng C., Shen Y., Huang W., Wayne M.M.Y., Xue H., Chee M.S., et al. The International HapMap Consortium. A haplotype map of the human genome. Nature. 2005;437:1299–1320. - PMC - PubMed
    1. The Cost of Sequencing a Human Genome. [(accessed on 16 June 2016)]; Available online: https://www.genome.gov/27565109/the-cost-of-sequencing-a-human-genome/

LinkOut - more resources